HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of growth factor Sadat-Habdan mesenchymal stimulating peptide in healing of burn wounds.

AbstractBACKGROUND:
Burns occur in everyday life and cause morbidity and mortality due to delayed healing. Many agents were tried to accelerate healing of burns. The aim of this study was to assess for the first time Sadat-Habdan mesenchymal stimulating peptide (SHMSP) known angiogenesis factor in healing of experimentally created burns in rats.
METHODS:
Forty male rats weighing (200-250 g) were randomly divided into 2 groups of 20 each. Under general anesthesia, reproducible, deep, partial-thickness, thermal burn injury was created by 1-cm aluminum template on the dorsal aspect of the body of each animal by heating the template at 80 °C for 10 seconds. Alternate rats were assigned to 1 of the 2 groups to minimize the difference of timing of the burn. Sadat-Habdan mesenchymal stimulating peptide 10 mg was applied on daily burn area, covered with a nonabsorbent dressing. All animals were kept in similar standard laboratory conditions. Its application continued 14 days as described by the inventors, and burned areas were photographed. On day 15, blood was collected from the animals for serum albumin levels, and the animals were killed, then the entire burn areas were excised for biopsy for general morphology and histopathology.
RESULTS:
There were no deaths among groups. The majority of the animals showed good to excellent healing compared with the control group. Clinical pictures revealed better healing in the SHMSP-treated group. Quantitative and qualitative analyses of images revealed significant contraction of burned areas. Image analysis showed that improved healing in the form of exaggerated fibroplasia in 19 of 20 in the study group and 11 of 20 in the control group. Regeneration of the panniculous muscle layer was observed in 19 of 20 of the study group and 5 of 20 of the control group. The mean vessel index in the study group was 53.18 ± 4.74 mm(2) and in the control group 23.7 ± 6.37 mm(2) (P < 0.001; confidence interval, 25.88-33.04), whereas the mean of vessel area density was 24.76 ± 7.35 versus 8.68 ± 4.04 mm(2) (P < 0.001; confidence interval, 12.28-19.88) in the control group. Histopathologic analysis by hematoxylin-eosin stain, CD31, and factor VIII stains showed significant angiogenesis in the quantity and quality of the new blood vessels in the study group compared with the control group.
CONCLUSIONS:
Sadat-Habdan mesenchymal stimulating peptide has potential of early healing of experimentally produced burns in rats. Healing was effective and better in the study group compared with the control group, in qualitative and quantitative measures.
AuthorsRola A Al-Hoqail, Mir Sadat-Ali, Ibrahim M Al-Habdan
JournalThe Journal of craniofacial surgery (J Craniofac Surg) Vol. 25 Issue 2 Pg. 639-44 (Mar 2014) ISSN: 1536-3732 [Electronic] United States
PMID24621713 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiogenesis Inducing Agents
  • Intercellular Signaling Peptides and Proteins
  • Peptides
  • Sadat-Habdan mesenchymal stimulating peptide
Topics
  • Angiogenesis Inducing Agents (therapeutic use)
  • Animals
  • Burns (drug therapy, pathology)
  • Disease Models, Animal
  • Intercellular Signaling Peptides and Proteins (therapeutic use)
  • Male
  • Neovascularization, Pathologic (drug therapy)
  • Peptides (therapeutic use)
  • Rats
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: